MedTrace Logo

Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule

NCT05003856 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2025-04-02

No results posted yet for this study

Summary

This phase IV trial studies the effect of radiofrequency ablation in treating patients with benign or low risk thyroid nodule. Radiofrequency ablation uses a needle to deliver a high-frequency electric current to kill tumor cells by heating them. The goal of this research study is to learn if ultrasound guided radiofrequency ablation can provide the same treatment result as standard surgical removal of the thyroid nodule, small primary thyroid, or thyroid cancers that have come back. Researchers also want to learn if the procedure can be less invasive and perhaps provide a better recovery response than surgery.

Conditions

  • Benign Thyroid Gland Neoplasm
  • Recurrent Thyroid Gland Carcinoma
  • Thyroid Gland Follicular Tumor of Uncertain Malignant Potential
  • Thyroid Gland Nodule
  • Thyroid Gland Papillary Carcinoma

Interventions

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Radiofrequency Ablation

Undergo RFA

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Kim O Learned · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-29
Primary Completion
2025-03-27
Completion
2025-03-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05003856 on ClinicalTrials.gov